Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Harrow, Inc. publishes a filing, an earnings call transcript or a press release.

Get HROW alerts

About Amir Shojaei

The proxy statement of Harrow, Inc. reports total compensation of $1,342,627 for Amir Shojaei in fiscal 2025, including a base salary of $441,346. Amir Shojaei has spoken on 3 earnings calls across 1 company, most recently for Harrow, Inc. on November 10, 2026. Harrow, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Harrow, Inc. includes Francis W. Mullery (CEO), Frank Mullery (CEO), John P. Saharek (CEO) and 7 others.

Amir Shojaei on recent calls

“Then the only thing I'll add is currently we don't have any plans for a second study or further studies in this line. That said, we do have quite a few ongoing studies with investigator-initiated trials within the IHESO franchise.”
Other, Third Quarter 2026 Earnings Conference Call and Webcast ·
“As I mentioned during our last quarterly webcast, we have now officially secured our pre-MDA meeting with the FDA, which is scheduled for early in the fourth quarter.”
Other, Second Quarter 2026 Earnings Conference Call and Webcast ·
“I wanted to spend a few minutes on G-Melt, our IV and opioid-free procedural sedation candidate. Having spent nearly 30 years in drug development advancing major global assets, I view G-MELT as a pipeline candidate of the highest caliber.”
Other, Harrow, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Harrow, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Harrow, Inc. (HROW) $441,346 $1,342,627

Recent activity